What is Sampre Nutritions Ltd (530617) share price return in the past 10 years?

Sampre Nutritions Ltd share price has declined -6.4% annually (CAGR) over the past ten years.

What is the share price of Sampre Nutritions Ltd (530617)?

Company share prices are keep on changing according to the market conditions. The current trading price of Sampre Nutritions Ltd (530617) on 02-Jul-2026 16:59:59 at 16:59 is 7.88.

What is the P/E ratio of Sampre Nutritions?

The latest standalone P/E ratio of Sampre Nutritions as of 02-Jul-2026 is 19.37.

What is the P/B ratio of Sampre Nutritions Ltd (530617)?

The latest standalone P/B ratio of Sampre Nutritions Ltd (530617) as of 02-Jul-2026 is 0.75.

What is the 52-week high and low of Sampre Nutritions Ltd (530617)?

The 52-week high of Sampre Nutritions Ltd (530617) is Rs. 42.33 and the 52-week low is Rs. 7.30.

Sampre Nutritions Ltd (530617) Share Analysis – Brand Strength, Quality & Valuation Zone & DeciZen Rating

Name: Sampre Nutritions Ltd (530617)
Brand: Sampre Nutritions

Sampre Nutritions Ltd (530617)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530617 NSE: Consumer Food | Small Cap | Sampre Nutritions Share Price

Sampre Nutritions Ltd (530617)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530617 NSE: Consumer Food | Small Cap | Sampre Nutritions Share Price

Key Metrics

Valuation Multiples

Market Cap

₹75 Cr.

Current Price

₹7.9

52-Week Low / High

₹7 / 42

TTM EPS

₹0.4

TTM Sales

₹43.4 Cr.

Book Value per Share

₹10.6

P/E Ratio

19.37

Lower than its 5-year historical median

Industry PE

Price to Book (P/B)

0.75

Lower than its 5-year historical median

Price to Sales (P/S)

1.73

Lower than its 5-year historical median

EV/EBITDA

15.50

In line with its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

-13.12%

Underperforms industry median

Return on Capital Employed (ROCE)

-7.13%

Underperforms industry median

Return on Assets (ROA)

-9.03%

Operating Profit Margin

-14.9%

Net Profit Margin

-29.09%

Gross Profit Margin

-20.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-0.12%

Operating Profit Growth (1 Year)

-188.81%

Net Profit Growth (1 Year)

-2458.06%

Asset Quality

Promoter Holding

14.04%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹53 Cr.

Equity

₹47.5 Cr.

Face Value

₹5

All Time Low / High

₹0.26 / 74.09

Sampre Nutritions stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Sampre Nutritions Ltd a good quality company?

Sampre Nutritions Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Sampre Nutritions Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Sampre Nutritions Ltd vs industry peers?

Sampre Nutritions Ltd revenue CAGR is 0.22%, compared to the industry median CAGR of 7.03%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Sampre Nutritions Ltd?

Promoters hold 14.04% of the Sampre Nutritions Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Sampre Nutritions Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -2.1% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	11.1%	8.8%	7.1%	8.7%	8.5%	5.3%	6.7%	6.6%	6.4%	-7.1%	-
Value Creation Index ⓘ	-0.2	-0.4	-0.5	-0.4	-0.4	-0.6	-0.5	-0.5	-0.5	-1.5	-
Growth Parameters ⓘ
Sales ⓘ	45.1	33.6	32.7	28.7	24.9	18.2	23.1	37.1	25.2	25.1	43
Sales YoY Gr.	-	-25.5%	-2.8%	-12.2%	-13.4%	-26.6%	26.9%	60.4%	-32.2%	-0.1%	-
Adj EPS ⓘ	0.5	0.2	0.1	0.1	0.2	0	0.2	0.1	0.1	-0.9	0.4
YoY Gr.	-	-50%	-43.5%	0%	38.5%	-77.8%	325%	-23.5%	-15.4%	-890.9%	-
BVPS (₹) ⓘ	4.9	5.1	5.2	5.4	5.6	5.6	5.8	6.9	7.1	10.8	10.6
Adj Net Profit ⓘ	0.9	0.5	0.2	0.2	0.3	0.1	0.3	0.4	0.3	-7.3	4
Cash Flow from Ops. ⓘ	1.2	-1	1.5	5.7	2.6	-0.2	2.4	0.9	4	0.1	-
Debt/CF from Ops. ⓘ	6.6	-12.6	9.4	3.5	7.8	-119.8	8.8	19.1	4.3	196.6	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-6.3%	0.2%	2.8%	-0.1%
Adj EPS ⓘ	-207.3%	-237%	-272.3%	-890.9%
BVPSⓘ	9.2%	14.3%	23.4%	52.9%
Share Price	-6.4%	13.8%	-28%	-13.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	9.9	4.7	2.4	2.4	3.2	0.7	3	2.2	1.4	-12.7	3.8
Op. Profit Mgn % ⓘ	6.2	8.9	9.3	13.1	15.7	18.8	15.2	10.9	16.7	-14.9	13.3
Net Profit Mgn % ⓘ	2	1.4	0.7	0.9	1.4	0.4	1.4	0.9	1.2	-29.1	9
Debt to Equity ⓘ	0.8	1.3	1.4	1.9	1.9	2	1.9	0.9	0.9	0.2	0.1
Working Cap Days ⓘ	71	119	128	160	192	277	241	168	268	282	76
Cash Conv. Cycle ⓘ	33	56	77	73	62	125	130	93	157	165	34

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	45.09	33.58	32.65	28.68	24.85	18.23	23.13	37.11	25.15	25.12
Operating Expenses ⓘ +	42.34	30.61	29.61	24.94	20.95	14.80	19.63	33.05	20.95	28.86
Manufacturing Costs	9.75	7.27	7.12	3.82	9.53	8.26	10.12	13.56	11.59	14.61
Material Costs	30.20	21.37	19.96	18.43	8.25	3.69	6.60	15.21	5.01	8.36
Employee Cost	0.33	0.44	0.71	0.71	0.81	0.67	0.72	1.25	1.14	1.19
Other Costs ⓘ	2.06	1.53	1.81	1.99	2.37	2.19	2.19	3.03	3.20	4.70
Operating Profit ⓘ	2.75	2.98	3.04	3.74	3.90	3.43	3.50	4.06	4.20	-3.73
Operating Profit Margin (%)	6.1%	8.9%	9.3%	13.0%	15.7%	18.8%	15.1%	10.9%	16.7%	-14.9%
Other Income ⓘ +	0.06	0.08	0.11	0.03	0.18	0.03	0.28	0.07	0.12	0.37
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.65	1.11	1.18	2.13	2.13	1.54	1.77	1.89	1.92	1.83
Depreciation ⓘ	1.15	1.29	1.48	1.40	1.49	1.81	1.63	1.82	1.83	1.97
Profit Before Tax ⓘ	1.01	0.66	0.48	0.24	0.46	0.11	0.37	0.42	0.57	-7.16
Tax ⓘ	0.15	0.21	0.24	0.01	0.12	0.03	0.06	0.07	0.26	0.15
Profit After Tax	0.86	0.45	0.24	0.23	0.34	0.08	0.31	0.35	0.31	-7.31
PAT Margin (%)	1.9%	1.4%	0.7%	0.8%	1.4%	0.4%	1.3%	0.9%	1.2%	-29.1%
Adjusted EPS (₹)	0.5	0.2	0.1	0.1	0.2	0.0	0.2	0.1	0.1	-0.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Sampre Nutritions - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	9.45	9.90	10.14	10.37	10.71	10.78	11.09	18.82	20.57	90.84
Share Capital ⓘ	4.82	4.82	4.82	4.82	4.82	4.82	4.82	6.87	7.27	21.01
Reserves ⓘ	4.63	5.08	5.32	5.55	5.89	5.96	6.27	11.95	13.30	69.83
Debt +	7.40	12.65	13.19	18.20	18.84	20.50	20.63	15.28	15.78	15.17
Long Term Debt	3.89	6.78	9.16	10.98	10.80	12.21	12.76	10.74	9.49	10.58
Short Term Debt	3.51	5.88	4.03	7.22	8.05	8.29	7.87	4.54	6.29	4.59
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	3.91	2.16	1.59	6.18	4.77	4.84	3.81	3.84	2.06	4.56
Others Liabilities ⓘ	3.06	1.45	2.35	3.32	3.07	2.16	2.17	5.65	6.42	6.51
Total Liabilities ⓘ	23.82	26.15	27.27	38.07	37.39	38.29	37.70	43.59	44.83	117.08
Fixed Assets
Net Fixed Assets ⓘ +	9.01	9.08	12.88	15.29	18.54	17.75	22.18	20.52	21.06	19.86
Gross Block	22.17	23.48	28.76	32.53	37.22	33.57	39.52	39.61	41.97	42.74
Accumulated Depreciation	13.16	14.39	15.88	17.24	18.68	15.83	17.33	19.08	20.91	22.89
CWIP ⓘ	3.86	5.58	2.39	8.88	5.42	5.30	0	4.16	5.50	5.01
Investments ⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.03	71.49
Inventories	2.49	3.59	4.93	5.93	7.04	7.29	7.09	7.04	7.58	5.71
Trade Receivables	6.05	4.84	4.53	4.99	3.58	6.22	5.97	7.47	6.72	8.85
Cash Equivalents	0.23	0.27	0.24	0.34	0.85	0.10	0.08	0.13	0.11	0.06
Others Assets ⓘ	2.16	2.77	2.30	2.62	1.96	1.61	2.36	4.25	3.83	6.10
Total Assets ⓘ	23.82	26.15	27.27	38.07	37.39	38.29	37.70	43.59	44.83	117.08

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1.19	-1.04	1.50	5.68	2.58	-0.18	2.41	0.88	4.03	0.09
PBT ⓘ	1.01	0.66	0.48	0.24	0.46	0.11	0.37	0.42	0.57	-7.16
Adjustment ⓘ	1.78	2.38	1.89	2.64	2.39	2.55	3.30	3.59	3.73	3.43
Changes in Working Capital ⓘ	-1.43	-3.82	-0.64	3.04	-0.02	-2.63	-0.95	-2.88	-0.48	3.93
Tax Paid ⓘ	-0.17	-0.27	-0.23	-0.24	-0.25	-0.21	-0.32	-0.26	0.22	-0.11
Cash Flow From Investing Activity ⓘ +	-4.32	-3.06	-2	-10.29	-1.26	-0.90	-0.76	-4.32	-3.95	-75.17
Capex	-4.34	-3.07	-2.10	-10.31	-1.28	-0.90	-0.77	-4.32	-3.71	-0.28
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.02	0.02	0.10	0.02	0.02	0	0	0	-0.25	-74.89
Cash Flow From Financing Activity ⓘ +	3.32	4.14	0.46	4.71	-0.82	0.33	-1.66	3.48	-0.09	75.03
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	9.72	1.08	77.32
Net Proceeds from Borrowing ⓘ	2.24	2.88	2.81	2.78	-0.72	0.82	0.55	-2.02	-1.25	1.10
Interest Paid ⓘ	-0.64	-1.11	-0.50	-1.26	-0.92	-0.74	-1.67	-1.78	-1.90	-1.70
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	1.73	2.37	-1.85	3.19	0.82	0.25	-0.54	-2.44	1.98	-1.69
Net Cash Flow ⓘ	0.20	0.04	-0.04	0.11	0.50	-0.75	-0.01	0.04	-0.02	-0.05

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	9.53	4.69	2.43	2.27	3.19	0.7	2.81	2.32	1.57	-13.12
ROCE (%)	11.14	8.79	7.06	8.71	8.45	5.26	6.65	6.57	6.38	-7.13
Asset Turnover Ratio	2.23	1.34	1.22	0.88	0.66	0.48	0.61	0.91	0.57	0.31
PAT to CFO Conversion(x)	1.38	-2.31	6.25	24.7	7.59	-2.25	7.77	2.51	13	N/A
Working Capital Days
Receivable Days	39.40	59.20	52.40	60.50	62.90	98.10	96.30	66.10	103	113.10
Inventory Days	15.80	33.10	47.60	69.10	95.20	143.40	113.50	69.50	106.10	96.60
Payable Days	30.80	51.80	34.20	77	242.40	476.10	239.60	91.90	215.10	144.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sampre Nutritions Ltd FAQs

The current trading price of Sampre Nutritions on 02-Jul-2026 16:59 is ₹7.88.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Sampre Nutritions stood at ₹74.87 Cr

The latest P/E ratio of Sampre Nutritions as of 01-Jul-2026 is 19.37.

The latest P/B ratio of Sampre Nutritions as of 01-Jul-2026 is 0.75.

The 52-week high of Sampre Nutritions is ₹42.33 and the 52-week low is ₹7.30.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sampre Nutritions is ₹43.35 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sampre Nutritions Ltd is a below average quality company.

The key valuation ratios of Sampre Nutritions Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sampre Nutritions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Sampre Nutritions Ltd

Sampre Nutritions was incorporated on December 3, 1991 as a Public company. Lately it was converted into a public limited company in 16 May 1994. The company is engaged in the manufacture and sale of sugar-boiled candies and toffees.

The multi-locational facilities of the Group are equipped with APV Baker 4 bank Deposited Line, New generation imported Uni plast lines cut & wrap lines, Cooling equipment and Packing machines. Continuous investments in the latest technology for each of the product lines have ensured the highest global standards. Supporting quality and optimum productivity across the integrated network are world-class laboratories and a strong R&D. The R&D also provides a one-stop source for everything from development to delivery of products to exacting international standards.

The companyâ€™s registered office is located at Kiran Arcade, 3 Floor, 100 Sarojini Devi Road Secunderabad,Andhra Pradesh-500003 .

Clientele

PROCTER & GAMBLE INDIA LTD
WARNER LAMBERT INDIA LTD
CADBURY INDIA LIMITED
INDIAN AIRLINES LTD
RANBAXY LABORATORIES LTD
KNOLL PHARMACEUTICALS LTD (BOOTS)
CIPLA LIMITED
DABUR INDIA LIMITED
AMRUTANJAN LIMITED
AUROBINDO PHARMA LIMITED
ANCHOR HEALTH & BEAUTY CARE PVT LTD
Dr. MOREPEN LABORATORIES LTD
HIMALAYA DRUG COMPANY
BAIDYANATH AYURVED BHAVAN PVT LTD
ELDER PHARMACEUTICALS LTD
MICRONUTRIENT, CANADA
ITC LIMITED

Awards and Achievements

The quality initiatives have credited the Group with many coveted citations viz., Pinnacle Awards by P&G, USA for Outstanding Quality Assurance Standards for 2 consecutive years, and the Golden Peacock National Quality Award in 1998 for Outstanding Quality Efforts in Small Sector Manufacturing.

The Rajiv Gandhi National Quality Award given by the Govt. of India and an ISO 9002 certification was topped by Sampre becoming the first confectionery Company in South East Asia to receive HACCP certification - the highest quality certification from BVQI â€“Netherlands for the Food industry.

Sampre Nutritions Ltd (530617)

Sampre Nutritions Ltd (530617)

Sampre Nutritions stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Sampre Nutritions - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sampre Nutritions Ltd FAQs

About Sampre Nutritions Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sampre Nutritions Ltd (530617)

Sampre Nutritions Ltd (530617)

Sampre Nutritions stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Sampre Nutritions - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sampre Nutritions Ltd FAQs

What is the share price of Sampre Nutritions?

What is the market cap of Sampre Nutritions?

What is the P/E ratio of Sampre Nutritions?

What is the P/B ratio of Sampre Nutritions?

What is the 52-week high and low of Sampre Nutritions?

What is the TTM revenue of Sampre Nutritions?

Is Sampre Nutritions Ltd a good quality company?

Is Sampre Nutritions Ltd undervalued or overvalued?

Is Sampre Nutritions Ltd a good buy now?

About Sampre Nutritions Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.